OTC Drug Review Hindered By Citizen Petition Proposed Rule - CHPA
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposal to ban citizen petitions on pending regulations "appear[s] to preclude the introduction of new data and information in the OTC drug review," the Consumer Healthcare Products Association argues in Feb. 28 comments.